Viewing Study NCT01667133


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-08 @ 10:37 PM
Study NCT ID: NCT01667133
Status: COMPLETED
Last Update Posted: 2022-06-13
First Post: 2012-08-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Sponsor: Ariad Pharmaceuticals
Organization: